Die internationale Fortbildung richtet sich an Nephrolog:innen, Internist:innen sowie Fellows der Nephrologie und Inneren Medizin. Das zweitägige Programm bietet ein Update zu zentralen Themen der Nephrologie, darunter IgA-Nephropathie, Lupusnephritis, CKD bei Adipositas und Typ-2-Diabetes, Elektrolytstörungen, Nierensteine, zystische Nierenerkrankungen, vaskuläre Zugänge, Transplantation und AKI.
PROGRAM Friday 27 March 2026:
09.05 – 09.50 Jonathan Barratt (Dpt of Cardiovascular Sciences, Univ. of Leicester) – Navigating the treatment landscape in IgA nephropathy
09.50 – 10.20 An De Vriese (AZ Sint-Jan, Brugge) – Oral anticoagulation in dialysis: Whom? Why? With what?
10.20 – 10.50 Hans Van Der Meersch (AZ Sint-Jan, Brugge) – A protocol for the management of osteoporosis in dialysis patients
11.10 – 11.55 Fernando Fervenza (Mayo Clinic, Rochester) – Redefining the treatment goals in lupus nephritis
11.55 – 12.40 Robert Hilbrands (UZ Brussel) – CKD in obesity and type 2 diabetes: rational use of GLP-1 analogues and SGLT-2 inhibitors
13.30 – 14.15 Ewout Hoorn (Erasmus Medical Centre, Rotterdam) – What’s new in electrolyte disorders?
14.15 – 15.00 John Lieske (Mayo Clinic, Rochester) – What’s new in kidney stones?
15.00 – 15.30 Dirk De Ridder (Leuvens Instituut voor Gezondheidszorgbeleid) – From electronic health records to sharing meaningful data
16.00 – 17.00 Dominique Persoone (The Chocolate Line) – A personal journey - chocolate tasting
17.00 – 18.00 Gert Meeus, Bart De Moor (NBVN) - Rethinking the role of nephrology in the healthcare of the future
18.00 – 19.00 Johan Kips (Sr Strategic Advisor to the Minister of Health and Social Affairs Frank Vandenbroucke) - Designing the future hospital landscape in Belgium
Program Saturday 28 March 2026
09.00 – 09.05 Welcome
09.05 – 09.50 Ulrich Specks (Mayo Clinic, Rochester) – ANCA vasculitis: towards personalized medicine
09.50 – 10.20 Sofie Dhaese (AZ Sint-Jan, Brugge) – Diagnostic challenges in TMA
10.20 – 10.50 Jens Van Praet (AZ Sint-Jan, Brugge) – Infectious diseases in immunocompromised renal patients
11.10 – 11.55 Monnie Wasse (Rush University Medical Center, Chicago) – Novelties in the hemodialysis vascular access
11.55 – 12.40 Emilie Cornec-Le Gall (Université de Brest) – Differential diagnosis of cystic kidney disease
13.30 – 14.15 Oriol Manuel (CHUV, Lausanne) – Management of viral infections after kidney transplantation
14.15 – 14.45 Stefaan Vandecasteele (AZ Sint-Jan Brugge) – Nephrotoxicity of antimicrobial agents
14.45 – 15.30 Kianoush Kashani (Mayo Clinic, Rochester) – Management of AKI in the ICU: Novelties in diagnosis and management
16.00 – 17.00 Fernando Fervenza (Mayo Clinic, Rochester), Elisabet Van Loon (Imelda, Bonheiden), Tess Van Meerhaeghe (Hôpital Erasme, Brussel), Lyssa Van De Ginste (AZ Groeninge, Kortrijk) – Treatment of glomerular diseases: a case-based approach